A number of studies have attempted to detect colorectal cancer lesions using fluorescently labeled antibodies against surface markers such as epidermal growth factor receptor (EGFR), CEA, or vascular endothelial growth factor (VEGF)27–29. This evidence concerns the gene EGFR and colorectal cancer.